
Sodium Iodide (I-131) Therapeutic Oral Solution
Radnostix is recalling Sodium Iodide (I-131) Therapeutic Oral Solution due to the presence of particulate matter.
Check your inventory for the affected order numbers and vial sizes. Do not use the product if it contains particulate matter and contact the manufacturer for return instructions.
Recall at a glance
- Quantity recalled
- 16 units
Why it was recalled
Radnostix is recalling specific orders of Sodium Iodide (I-131) Therapeutic Oral Solution due to the presence of particulate matter identified during production. This recall affects multiple vial sizes and order numbers distributed nationwide in the USA and Puerto Rico.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Sodium Iodide (I-131) Solution, Therapeutic Oral
- NDC / UPC
- NDC 69208-003-15, NDC 69208-003-25, NDC 69208-003-35
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other recent recalls from Radnostix
Editorial summary by Recall Canary · summary updated 2026-06-11 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification
